Save $30 on a Pro or Premium
account
<ASX Spectator>
Archive
Sponsorship
Newsletter
Contact
<AD>
ALA
2023
<LINK>
Arovella Therapeutics (ASX:ALA) Gains on License to Develop Cancer Cell Therapy
Oct 12, 2023
